QLINE — Q-Line Biotech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Q-Line Biotech, fiscal year end - March 31st, millions except per share.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | |
| Standards: | — | IAS | IAS | IAS |
| Status: | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | 298 | 306 | 442 |
| Depreciation | ||||
| Non-Cash Items | — | 27.4 | 49.2 | -192 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | -97.5 | -636 | -336 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | — | 499 | -484 | -26.4 |
| Capital Expenditures | — | -263 | -489 | -563 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | -0.468 | 42.1 | -28.3 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | -526 | -894 | -1,182 |
| Financing Cash Flow Items | — | -38 | -62.8 | -147 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | 528 | 340 | 1,067 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | — | 251 | -519 | -70.7 |